% Expired Patents = 66.7

CIPO Patents = 2

EPO Patents = 4

Trademarks = 1

Forward Citations = 101

Loading Chart...

4 inventors (with patents filed for the assignee):

Andrew Heaton (6 out of 19 patents)

Alan James Husband (5 out of 13 patents)

Naresh Kumar (1 out of 12 patents)

4. Catherine Walker (1 out of 1 patent)

5. Alan Husband (0 patent)

6. Andrew Heaton (0 patent)

6 patents: Sort by Forward Citations

1. 8697891 - Substituted chroman derivatives, medicaments and use in therapy (2014-04-15),

2. 8461361 - Chroman derivatives, medicaments and use in therapy (2013-06-11),

3. 8367659 - Oxazinyl isoflavonoid compounds, medicaments and use (2013-02-05),

4. 8163795 - Chroman derivatives, medicaments and use in therapy (2012-04-24),

5. 8084628 - Substituted chroman derivatives, medicaments and use in therapy (2011-12-27),

6. 8080675 - Chroman derivatives, medicaments and use in therapy (2011-12-20),

Company Overview

Marshall Edwards, Inc. is a cutting-edge biopharmaceutical company focused on developing innovative oncology therapies. With a strong emphasis on research and development, we strive to bring new treatments to patients in need. Our team of dedicated scientists and experts work tirelessly to discover and advance promising drug candidates. Visit our website to learn more about our mission and pipeline of potential therapies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

6 Patents

#762 in San Diego, CA

#10,565 in California

#44,949 in US

San Diego, CA, United States of America

Marshall Edwards, Inc.

Forward Citations = 101

4 inventors:

Andrew Heaton (6 out of 19 patents)

Alan James Husband (5 out of 13 patents)

Naresh Kumar (1 out of 12 patents)

4. Catherine Walker (1 out of 1 patent)

5. Alan Husband (0 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Marshall Edwards, Inc.. Retrieved from https://idiyas.com/company/marshall-edwards

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]